JP2013511974A5 - - Google Patents

Download PDF

Info

Publication number
JP2013511974A5
JP2013511974A5 JP2012540491A JP2012540491A JP2013511974A5 JP 2013511974 A5 JP2013511974 A5 JP 2013511974A5 JP 2012540491 A JP2012540491 A JP 2012540491A JP 2012540491 A JP2012540491 A JP 2012540491A JP 2013511974 A5 JP2013511974 A5 JP 2013511974A5
Authority
JP
Japan
Prior art keywords
gsk
inhibitor
alkyl
cells
embryonic stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012540491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013511974A (ja
Filing date
Publication date
Priority claimed from GB0920865A external-priority patent/GB0920865D0/en
Priority claimed from GBGB1002329.9A external-priority patent/GB201002329D0/en
Application filed filed Critical
Priority claimed from PCT/GB2010/002184 external-priority patent/WO2011064549A2/en
Publication of JP2013511974A publication Critical patent/JP2013511974A/ja
Publication of JP2013511974A5 publication Critical patent/JP2013511974A5/ja
Pending legal-status Critical Current

Links

JP2012540491A 2009-11-27 2010-11-26 ヒト胚性幹細胞の分化のための組成物および方法 Pending JP2013511974A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0920865A GB0920865D0 (en) 2009-11-27 2009-11-27 Composition and method for differentiation of human embryonic stem cells
GB0920865.3 2009-11-27
GBGB1002329.9A GB201002329D0 (en) 2010-02-11 2010-02-11 Composition and method for differentiation of human embryonic stem cells
GB1002329.9 2010-02-11
PCT/GB2010/002184 WO2011064549A2 (en) 2009-11-27 2010-11-26 Composition and method for differentiation of human embryonic stem cells

Publications (2)

Publication Number Publication Date
JP2013511974A JP2013511974A (ja) 2013-04-11
JP2013511974A5 true JP2013511974A5 (enExample) 2013-11-28

Family

ID=43827702

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012540491A Pending JP2013511974A (ja) 2009-11-27 2010-11-26 ヒト胚性幹細胞の分化のための組成物および方法

Country Status (5)

Country Link
US (1) US8815590B2 (enExample)
EP (1) EP2470643A2 (enExample)
JP (1) JP2013511974A (enExample)
CN (1) CN102834505A (enExample)
WO (1) WO2011064549A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2502704B (en) 2010-11-15 2019-12-04 Accelerated Biosciences Corp Generation of neural stem cells from human trophoblast stem cells
CA3137404A1 (en) 2012-11-30 2014-06-05 Accelerated Biosciences Corp. Pancreatic progenitor cells expressing betatrophin and insulin
EP2961829A4 (en) 2013-02-27 2016-08-17 Univ California GENERATION OF THYME PEPPER THERAPEUTIC CELLS IN VITRO
JP6836990B2 (ja) 2014-11-26 2021-03-03 アクセラレイテッド・バイオサイエンシズ・コーポレーション 誘導肝細胞およびそれらの使用
CN105115951B (zh) * 2015-08-10 2018-01-26 山东省科学院生物研究所 一种快速评价化合物对斑马鱼肝脏功能损伤作用的方法
CN111876380B (zh) * 2020-08-04 2022-06-28 浙江大学 使人胚胎干细胞分化成间充质干细胞的诱导培养基

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282366B2 (en) * 2000-04-27 2007-10-16 Geron Corporation Hepatocytes for therapy and drug screening made from embryonic stem cells
CA2695225C (en) * 2007-07-31 2021-06-01 Lifescan, Inc. Differentiation of human embryonic stem cells to pancreatic endocrine
US8623648B2 (en) 2008-04-24 2014-01-07 Janssen Biotech, Inc. Treatment of pluripotent cells
DK2297319T3 (en) * 2008-06-03 2015-10-19 Viacyte Inc GROWTH FACTORS FOR PREPARING DEFINITIVE ENDODERM

Similar Documents

Publication Publication Date Title
JP2013511974A5 (enExample)
RU2732240C2 (ru) Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток
JP2013513621A5 (enExample)
AR070535A1 (es) Compuestos inhibidores de raf y metodos para usarlos
AR088000A1 (es) Derivados de pirazolquinolinona, su preparacion y su uso terapeutico
WO2012081898A3 (ko) 위암의 예후 예측용 마커 및 이를 이용하는 위암의 예후 예측 방법
Eubanks et al. Tooth storage, dental pulp stem cell isolation, and clinical scale expansion without animal serum
UY33337A (es) DERIVADOS SUSTITUIDOS DE 1H-PIRAZOL[ 3,4-d]PIRIMIDINA COMO INHIBIDORES DE LAS FOSFOINOSITIDA 3-QUINASAS
JP2011512323A5 (enExample)
ATE486126T1 (de) Lebervorläuferzellen
ECSP13012692A (es) Compuestos tricíclicos inhibidores de la pi3k y métodos de uso
AR083058A1 (es) Compuestos de estructura de imidazotriazinona
BRPI0813729B8 (pt) métodos de preparação de massas celulares de cardiomiócitos purificados derivados de células-tronco pluripotentes e de uma película de massas celulares de cardiomiócitos, bem como dispositivo médico e uso das referidas massas celulares
CU20120084A7 (es) Compuestos derivados de triazolopiridina sustituidos como inhibidores de la quinasa mps-1 y compuestos intermediarios para su preparación
EP2746281A3 (de) 7-Azaindolderivate
Guo et al. A novel in vitro model system for smooth muscle differentiation from human embryonic stem cell-derived mesenchymal cells
AR082519A1 (es) Fenilamidinas que tienen alta actividad fungicida, y su utilizacion
JP2010524894A5 (enExample)
RU2012139033A (ru) Bir домен iap связывающие соединения
JP2012519653A5 (enExample)
RU2016146567A (ru) Способ дифференцировки плюрипотентных стволовых клеток в кардиомиоциты
JP2016529920A5 (enExample)
RU2015148585A (ru) Улучшение органов для трансплантации
JP2022517300A (ja) インビトロで肝細胞を増殖・培養する方法及び応用
WO2005007838A1 (ja) 細胞分化抑制剤、これを用いた細胞培養方法、培養液及び培養された細胞株